...
首页> 外文期刊>Coordination chemistry reviews >Non-conventional photoactive transition metal complexes that mediated sensing and inhibition of amyloidogenic aggregates
【24h】

Non-conventional photoactive transition metal complexes that mediated sensing and inhibition of amyloidogenic aggregates

机译:介导的感测和抑制淀粉样蛋白聚集体的非传统光活性过渡金属配合物

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer's disease (AD), a devastating neurodegenerative disease, is associated with the abnormal accumulation and aggregation of beta-amyloid proteins (A beta) along with the deposition of high levels of Cu, Fe and Zn ions in the brain, causing neuronal cell deaths to lead the cognitive disabilities and even death. As there is a direct relationship between AD and A beta aggregation, an intense research activity has been made to develop drug materials that serve as probes and inhibitors for controlling the pathways of A beta peptide aggregation. However, their relatively instability in aqueous medium, tedious sample treatment, multistep syntheses, or low detection ability limit their potential applications. Therefore, the development of photoactive metal complexes for the selective detection and inhibition effects of A beta aggregation is a thrust area in biomedical research. In this review, the use of non-conventional photoactive metal complexes including Ru(II), Re(I), Ir(III) and Pt(II) has the potential advantages of probes for monitoring and inhibiting the fibrillation as well as the toxicity of A beta over conventional dyes such as Thioflavin T (ThT). The geometry, multiple electronic/spin states and redox nature of metal centres have made them tunable properties. Upon binding to the A beta peptide aggregates, they exhibit promising potential as anti-AD agents due to their fascinating photophysical properties include red emissions, large Stokes shifts, and long lifetimes, which differentiate the competitive binding of other short-lived fluorescent molecules via photoluminescence, and time-resolved measurements. In addition, metal complexes display their remarkable selectivity and superiority over ThT. Competition study between photoactive metal complexes and ThT on fibrillation process show their effective binding of metal complex with A beta(42) fibrils by hindering the ThT binding to give higher binding constants than that of ThT. Computational studies predicted a hydrophobic domain between amino acid binding sites and the functional group of photoactive metal complexes via different noncovalent interactions. Thus, attractive characteristics of photoactive metal complexes could influence remarkable evolutions in new dimensions, which in turn address current challenges in the clinical use of the detection and inhibition of A beta fibrils. (C) 2020 Elsevier B.V. All rights reserved.
机译:Alzheimer的疾病(AD)是一种毁灭性的神经变性疾病,与β-淀粉样蛋白(Aβ)的异常积累和聚集以及大脑中的高水平Cu,Fe和Zn离子的沉积有关,导致神经元细胞死亡引领认知残疾甚至死亡。由于AD和β聚集之间存在直接关系,因此已经进行了激烈的研究,以开发用于控制β肽聚集的途径的探针和抑制剂的药物材料。然而,它们在含水介质中的相对不稳定,繁琐的样品处理,多体合成或低检测能力限制了它​​们的潜在应用。因此,对β聚集的选择性检测和抑制效果的光活性金属配合物的发展是生物医学研究中的推力区域。在该综述中,使用包括ru(II),Re(I),IR(III)和Pt(II)的非常规光活性金属配合物具有监测和抑制颤动以及毒性的潜在优点在常规染料中的β如硫蛋白T(THT)。金属中心的几何形状,多重电子/旋转状态和氧化还原性质使它们进行了可调性。在与β肽聚集体的结合后,它们具有由于其迷人的光物理性质而具有抗Ad剂的有希望的潜力,包括红色排放,大的斯托克斯偏移和长的寿命,这通过光致发光区分了其他短寿命分子的竞争结合,和时间解决的测量。此外,金属配合物在THT上显示出显着的选择性和优越性。光活性金属络合物与THT在原纤化过程中的竞争研究表明,通过阻碍THT结合来使金属络合物与β(42)原纤维的有效结合,得到比THT的更高的结合常数。计算研究通过不同的非共价相互作用预测氨基酸结合位点与光活性金属配合物的官能团之间的疏水结构域。因此,光活性金属配合物的有吸引力的特性可能影响新尺寸的显着演变,这反过来解决了在临床使用中临床使用β原纤维的挑战。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号